Taylor Swift’s Eras Toυr Strυggles with Oпly 2,000 Ticket Sales After Eпdorsemeпt Backlash Full story below👇

Taylor Swift’s Eras tour is the first tour to cross the billion-dollar mark, according to Pollstar’s 2023 year-end charts.

Not only was Swift’s landmark Eras Tour the number one tour both worldwide and in North America, but she also brought in $1.04bn with 4.35m tickets sold across 60 tour dates, the concert trade publication found.

Cultural conversation … Taylor Swift in November during her Eras Tour.
Taylor Swift lambasts music industry as she’s named Time magazine’s person of the year
Read more
Pollstar data is pulled from box office reports, venue capacity estimates, historical Pollstar venue ticket sales data and other undefined research, collected from 17 November 2022 to 15 November 2023.

Representatives for the publication did not immediately clarify if they adjusted past tour data to match 2023 inflation in naming Swift the first to break the billion-dollar threshold.

Pollstar also found that Swift brought in approximately $200m in merchandise sales and her blockbuster film adaptation of the tour, Taylor Swift: The Eras Tour, has reportedly earned approximately $250m in sales, making it the highest-grossing concert film of all time.

According to their estimates, Pollstar predicts a big 2024 for Swift as well. The magazine projects the Eras Tour will once again reach $1bn within their eligibility window, meaning Swift is likely to bring in over $2bn over the span of the tour.

Worldwide, Swift’s tour was followed by Beyoncé in second, Bruce Springsteen & The E Street Band in third, Coldplay in fourth, Harry Styles in fifth, and Morgan Wallen, Ed Sheeran, Pink, The Weeknd and Drake.

In North America, there was a similar top 10: Swift, followed by Beyoncé, Morgan Wallen, Drake, Pink, Bruce Springsteen & The E Street Band, Ed Sheeran, George Strait, Karol G and RBD.

For concert sales 2023 was a landmark year: worldwide, the top 100 tours of the year saw a 46% jump from last year, bringing in $9.17bn compared to 2022’s $6.28bn.